Brain tumors and neuro-oncology are integral to addressing the complexities of primary and secondary brain cancers. This specialized field encompasses a range of treatment options, from surgery and radiation therapy to cutting-edge drug therapies and clinical trials exploring new drug combinations. Researchers are focused on overcoming the challenges posed by the blood-brain barrier to deliver effective treatments. With the advent of immunotherapy, CAR-T cell therapies, and personalized genetic profiling, the landscape of neuro-oncology is rapidly changing. The development of non-invasive diagnostic tools and predictive models is also helping clinicians better assess tumor behavior and patient prognosis. This research is instrumental in improving long-term outcomes and offering hope to patients affected by malignant brain tumors.
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Modeling early neurologic trajectories after elevated leg positioning (ELP): A secondary analysis of the LEG-UP randomized feasibility study
Kayode Ahmed, The University of Texas MD Anderson Cancer Center, United States
Title : Neuro-exergaming for non-verbal autism spectrum: A case study of neuropsychological function after 15 sessions of pedal-n-play iPACES
Cay Anderson Hanley, iPACES, United States
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States